Avifavir, described by its developers in Russia as perhaps the most promising anti COVID-19 drug in the world, is derived from Favipiravir. Mumbai-based Glenmark Pharmaceuticals announced last week that Favipiravir is under phase 3 clinical trials.
from Top India News- News18.com https://ift.tt/3eD9prS
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment